Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drug

Biktarvy(Bictegrav/Emtricit/Tenofov Ala)Gilead Sciences, Inc. logoGILD

Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by Gilead Sciences, Inc.

$3.45B

Medicare cost, 2024

Medicare drug plans spent $3.5 billion on Biktarvy (bictegrav/emtricit/tenofov ala) in 2024, for 840,473 prescriptions and refills filled by 92,204 patients. It ranks 13th among all drugs by Medicare drug plan spending. At about $4,111 per prescription it is a high-cost drug. Florida accounts for the most spending ($415.7 million, 12% of the total).

Medicare cost, 2024

$3.45B

+9.6% from 2023

Prescriptions

840K

$4,110.59 per claim

Patients

92K

28,169 prescribers

Total spending, 2024

$3.46B

$37,465.70 per patient

Questions and answers

How much does Medicare spend on Biktarvy?

Medicare prescription drug plans paid $3.45B for Biktarvy in 2024, for 840,473 prescriptions and refills to 92,204 patients (up 9.6% from 2023). The average cost per claim was $4,110.59.

Which state spends the most on Biktarvy?

Florida had the highest Medicare cost for Biktarvy in 2024: $415.7M for 103,739 claims, followed by New York ($396.9M).

Who prescribes Biktarvy the most?

Ronald Cathcart, internal medicine in Melbourne, FL, had the highest Medicare cost for Biktarvy in 2024: 1,591 claims costing $6.2M.

Who makes Biktarvy?

Biktarvy is made by Gilead Sciences, Inc. (GILD), listed in the Medicare spending data as Gilead Sciences.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Biktarvy was $3.46B in 2024, the highest year shown.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Biktarvy, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Ronald Cathcart Melbourne, FLInternal Medicine1,591153$6.2M
Dong Phuong H Nguyen San Francisco, CAPharmacist559165$6.0M
Federico Hinestrosa Orlando, FLInfectious Disease1,431155$5.8M
Akinwale O Olatosi Camden, SCInternal Medicine1,415141$5.4M
Marc A Johnson Charlotte, NCInternal Medicine1,217126$5.0M
Sharon D Reiley Jacksonville, FLNurse Practitioner1,223135$4.8M
Joseph C Gathe Jr. Houston, TXInfectious Disease1,062125$4.4M
Rosa O Diring Norfolk, VANurse Practitioner1,059124$4.3M
Jeffrey K Claus Albany, NYPhysician Assistant1,045138$4.3M
Stephen A Renae Fort Lauderdale, FLInfectious Disease1,137153$4.3M
Jeena Mathew Bartow, FLNurse Practitioner1,060159$4.0M
Harmeet S Gill Columbia, SCHospitalist995101$3.8M
Rafael Martinez San Antonio, TXFamily Practice94291$3.8M
Pamela L Burian Los Angeles, CAPhysician Assistant96497$3.7M
Thomas P Poirier Gainesville, FLInfectious Disease914102$3.7M
Ellen Tedaldi Philadelphia, PAInternal Medicine955120$3.7M
Melissa M Stevenson Albany, GANurse Practitioner972138$3.7M
Tessa Gomez New York, NYInternal Medicine954125$3.7M
Alireza Farabi Las Vegas, NVInternal Medicine902147$3.7M
Gerald R Hamwi Los Angeles, CAFamily Practice95192$3.7M
Michael Robinson Riverside, CAFamily Practice942110$3.6M
Ethan T Dungan Birmingham, ALNurse Practitioner901102$3.5M
Ann E Stapleton Palm Springs, CAInternal Medicine80991$3.5M
Terry L Wilder Orlando, FLNurse Practitioner837109$3.5M
John W Hogan Washington, DCInternal Medicine871101$3.5M

Prescriber data by year

YearPrescribersClaimsPatientsCost
202221,585685,94275,752$2.70B
202325,068756,25483,793$3.15B
202428,169840,47392,204$3.45B

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Gilead SciencesGILD logoGILD840,772$3.46B

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube